• Inflammation and Cardiometabolic Disease Edition: hs-CRP and Cardiovascular Disease

  • 2024/11/12
  • 再生時間： 23 分
  • ポッドキャスト

Inflammation and Cardiometabolic Disease Edition: hs-CRP and Cardiovascular Disease

無料で聴く

ポッドキャストの詳細を見る

  • サマリー

  • Host: Darryl S. Chutka, M.D. [@chutkaMD]

    Guest: Regis I. Fernandes, M.D.

    Inflammation commonly occurs as a response to injury or infection but can lead to damage when it develops in healthy tissue. It’s now known that inflammation plays a key role in the development of cardiovascular disease. It produces damage to the endovascular arterial cells allowing plaque to form within the artery leading to stenosis, thereby reducing coronary blood flow. What initiates the inflammatory response as it develops in otherwise healthy arteries? How should we use the hs-CRP in measuring inflammation in cardiovascular disease? Does our management of cardiovascular disease result in a decrease in hs-CRP? These are some of the questions I’ll be asking my guest, Regis I. Fernandes, M.D., a preventive cardiologist from the Mayo Clinic as we discuss “hs-CRP and Cardiovascular Disease”.

    These talks on Inflammation and Cardiometabolic Disease are sponsored by Novo Nordisk

    Learn more about this series HERE

    Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

    続きを読む 一部表示

あらすじ・解説

Host: Darryl S. Chutka, M.D. [@chutkaMD]

Guest: Regis I. Fernandes, M.D.

Inflammation commonly occurs as a response to injury or infection but can lead to damage when it develops in healthy tissue. It’s now known that inflammation plays a key role in the development of cardiovascular disease. It produces damage to the endovascular arterial cells allowing plaque to form within the artery leading to stenosis, thereby reducing coronary blood flow. What initiates the inflammatory response as it develops in otherwise healthy arteries? How should we use the hs-CRP in measuring inflammation in cardiovascular disease? Does our management of cardiovascular disease result in a decrease in hs-CRP? These are some of the questions I’ll be asking my guest, Regis I. Fernandes, M.D., a preventive cardiologist from the Mayo Clinic as we discuss “hs-CRP and Cardiovascular Disease”.

These talks on Inflammation and Cardiometabolic Disease are sponsored by Novo Nordisk

Learn more about this series HERE

Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

続きを読む 一部表示

Inflammation and Cardiometabolic Disease Edition: hs-CRP and Cardiovascular Diseaseに寄せられたリスナーの声

カスタマーレビュー：以下のタブを選択することで、他のサイトのレビューをご覧になれます。

Audible.co.jp

Amazon.co.jp
レビューはまだありません。